<DOC>
	<DOCNO>NCT00990626</DOCNO>
	<brief_summary>The purpose study determine whether Seroquel XR treatment 6 month improve relapse prevention schizophrenic outpatient</brief_summary>
	<brief_title>Seroquel XR Schizophrenia Relapse Prevention</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Schizophrenic outpatient least 600 mg Seroquel XR treatment least 1 month Severe cerebro cardiovascular disease , severe hepatic impairment , gravidity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Seroquel XR</keyword>
	<keyword>schizophrenia relapse prevention</keyword>
</DOC>